The Medical Letter on Drugs and Therapeutics
Nebivolol (Bystolic) for Hypertension
March 10, 2008 (Issue: 1281)Nebivolol (Bystolic - Forest) is a new beta-blocker that has been approved by the FDA for treatment of hypertension. It has been marketed in Europe since 1999 for treatment of hypertension and heart failure.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.